1. Home
  2. CADL vs MVIS Comparison

CADL vs MVIS Comparison

Compare CADL & MVIS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Candel Therapeutics Inc.

CADL

Candel Therapeutics Inc.

HOLD

Current Price

$10.84

Market Cap

1.0B

Sector

Health Care

ML Signal

HOLD

Logo MicroVision Inc.

MVIS

MicroVision Inc.

HOLD

Current Price

$1.68

Market Cap

86.6M

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
CADL
MVIS
Founded
1999
1993
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Industrial Machinery/Components
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
1.0B
86.6M
IPO Year
2021
2010

Fundamental Metrics

Financial Performance
Metric
CADL
MVIS
Price
$10.84
$1.68
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
7
3
Target Price
$19.00
$2.25
AVG Volume (30 Days)
1.1M
1.3M
Earning Date
05-14-2026
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
58.62
23.91
EPS
N/A
N/A
Revenue
$125,000.00
$664,000.00
Revenue This Year
N/A
$529.06
Revenue Next Year
N/A
$168.46
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$4.35
$0.23
52 Week High
$14.00
$4.90

Technical Indicators

Market Signals
Indicator
CADL
MVIS
Relative Strength Index (RSI) 41.77 49.54
Support Level $9.40 $1.65
Resistance Level $11.36 $1.93
Average True Range (ATR) 0.69 0.13
MACD -0.28 -0.02
Stochastic Oscillator 27.99 65.48

Price Performance

Historical Comparison
CADL
MVIS

About CADL Candel Therapeutics Inc.

Candel Therapeutics Inc is a clinical stage biopharmaceutical company focused on developing off-the-shelf viral immunotherapies that elicit an individualized, systemic anti-tumor immune response to help patients fight cancer. The immune cells induced by these viral immunotherapies are believed to target patients' specific tumor antigens, potentially improving responses in immunologically hot tumors while at the same time infiltrating the tumor microenvironment, transforming non-inflamed cold tumors with limited immune response into hot tumors. The company has established two clinical off-the-shelf viral immunotherapy platforms based on novel, genetically modified adenovirus and herpes simplex virus (HSV) constructs, respectively.

About MVIS MicroVision Inc.

Microvision Inc is engaged in developing a lidar sensor to be used in automotive safety and autonomous driving applications. Its lidar sensor uses laser beam scanning (LBS) technology, which is based on systems that include micro-electrical mechanical systems (MEMS), laser diodes, opto-mechanics, electronics, algorithms, and software. The company has also developed solutions for Augmented Reality, Interactive Displays, and Consumer Lidars. Geographically, the company operates in United States, Germany, and Other foreign countries.

Share on Social Networks: